Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
- September -
Oktober
-
November
-
December
|
2002
-
2003
-
2004
- 2005 -
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
September 2005 - 93 products
IP
CI
Cefuroxim Sandoz 500mg
14
15.00
32.75
10 %
Coated tablets: Cefuroximum 500 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Cefuroxim Sandoz 250mg
-
T
14
PR
PR
k.A.
Coated tablets: Cefuroximum 250 mg
Sandoz
Pharmaceuticals AG
A
FB
G
IP
CI
Cefuroxim Sandoz 250mg
-
T
10 x 14
PR
PR
k.A.
Coated tablets: Cefuroximum 250 mg
Sandoz
Pharmaceuticals AG
A
FB
G
IP
CI
Cefuroxim Sandoz 500mg
10 x 14
PR
PR
k.A.
Coated tablets: Cefuroximum 500 mg
Sandoz
Pharmaceuticals AG
A
FB
G
IP
CI
Metoject 7.5 mg
syringe(s)
12.93
30.50
10 %
Injection solution: Methotrexatum 7.5mg / 0.15ml
Gebro Pharma AG
A / SL / SO
FB
G
IP
CI
Metoject 10 mg
syringe(s)
15.11
32.85
10 %
Injection solution: Methotrexatum 10mg / 0.2ml
Gebro Pharma AG
A / SL / SO
FB
G
IP
CI
Metoject 15 mg
syringe(s)
17.69
35.60
10 %
Injection solution: Methotrexatum 15mg / 0.3ml
Gebro Pharma AG
A / SL / SO
FB
G
IP
CI
Metoject 20 mg
syringe(s)
20.40
38.50
10 %
Injection solution: Methotrexatum 20mg / 0.4ml
Gebro Pharma AG
A / SL / SO
FB
G
IP
CI
Metoject 25 mg
syringe(s)
22.85
41.20
10 %
Injection solution: Methotrexatum 25mg / 0.5ml
Gebro Pharma AG
A / SL / SO
FB
G
IP
CI
Metoject 30 mg
syringe(s)
26.51
45.15
10 %
Injection solution: Methotrexatum 30mg / 0.6ml
Gebro Pharma AG
A / SL / SO
FB
G
IP
CI
Metoject 12.5 mg
syringe(s)
16.84
34.65
10 %
Injection solution: Methotrexatum 12.5mg / 0.25ml
Gebro Pharma AG
A / SL / SO
FB
G
IP
CI
Metoject 17.5 mg
syringe(s)
19.36
37.40
10 %
Injection solution: Methotrexatum 17.5mg / 0.35ml
Gebro Pharma AG
A / SL / SO
FB
G
IP
CI
Metoject 22.5 mg
syringe(s)
21.97
40.20
10 %
Injection solution: Methotrexatum 22.5mg / 0.45ml
Gebro Pharma AG
A / SL / SO
FB
G
IP
Eloxatine 50 mg/10 ml
Durchstechflasche(n)
84.32
107.65
10 %
Concentrate for infusion: Oxaliplatinum 50mg / 10ml
Sanofi-Aventis
(Suisse) SA
A / SL / SO
FB
G
IP
Eloxatine 100 mg/20 ml
Durchstechflasche(n)
168.03
198.20
10 %
Concentrate for infusion: Oxaliplatinum 100mg / 20ml
Sanofi-Aventis
(Suisse) SA
A / SL / SO
FB
G
IP
Eloxatine 200 mg/40 ml
Durchstechflasche(n)
289.02
329.15
10 %
Concentrate for infusion: Oxaliplatinum 200mg / 40ml
Sanofi-Aventis
(Suisse) SA
A / SL / SO
FB
G
IP
CI
Meto Zerok 25
-
T
30 Tablet(s)
2.28
11.70
10 %
Delayed release tablets: Metoprololi Tartras 25 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Meto Zerok 25
-
T
100 Tablet(s)
6.60
16.40
10 %
Delayed release tablets: Metoprololi Tartras 25 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Meto Zerok 50
-
T
30 Tablet(s)
3.73
13.30
10 %
Delayed release tablets: Metoprololi Tartras 50 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Meto Zerok 50
-
T
100 Tablet(s)
10.55
27.90
10 %
Delayed release tablets: Metoprololi Tartras 50 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Meto Zerok 100
-
T
30 Tablet(s)
6.10
15.85
10 %
Delayed release tablets: Metoprololi Tartras 100 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Meto Zerok 100
-
T
100 Tablet(s)
17.30
35.20
10 %
Delayed release tablets: Metoprololi Tartras 100 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Meto Zerok 200
30 Tablet(s)
7.48
17.35
10 %
Delayed release tablets: Metoprololi Tartras 200 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Meto Zerok 200
100 Tablet(s)
21.48
39.75
10 %
Delayed release tablets: Metoprololi Tartras 200 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Fluoxetin-Mepha
Dispersible 20 mg
10 Tablet(s)
3.21
12.80
10 %
Dispersible Tablets: Fluoxetinum 20 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
CI
Fluoxetin-Mepha
Dispersible 20 mg
30 Tablet(s)
9.66
26.90
10 %
Dispersible Tablets: Fluoxetinum 20 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
CI
Fluoxetin-Mepha
Dispersible 20 mg
100 Tablet(s)
35.27
54.70
10 %
Dispersible Tablets: Fluoxetinum 20 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
IP
CI
Emselex 7.5 mg
-
T
14 Tablet(s)
10.20
27.50
10 %
Delayed release tablets: Darifenacinum 7.5 mg
CPS Cito Pharma
Services GmbH
B / SL
FB
G
IP
CI
Emselex 7.5 mg
-
T
56 Tablet(s)
40.77
60.75
10 %
Delayed release tablets: Darifenacinum 7.5 mg
CPS Cito Pharma
Services GmbH
B / SL
FB
G
IP
CI
Emselex 15 mg
-
T
14 Tablet(s)
10.20
27.50
10 %
Delayed release tablets: Darifenacinum 15 mg
CPS Cito Pharma
Services GmbH
● 
B / SL
FB
G
IP
CI
Emselex 15 mg
-
T
56 Tablet(s)
40.77
60.75
10 %
Delayed release tablets: Darifenacinum 15 mg
CPS Cito Pharma
Services GmbH
B / SL
FB
G
IP
CI
Fluimucil 600 mg
12 Tablet(s)
6.41
9.05
10 %
Tablets: Acetylcysteinum 600 mg
Zambon Svizzera SA
D / SL
FB
G
IP
CI
Fluimucil 600 mg
30 Tablet(s)
14.10
31.75
10 %
Tablets: Acetylcysteinum 600 mg
Zambon Svizzera SA
B / SL
FB
G
L
IP
CI
Fluimucil 600 mg
60 Tablet(s)
25.32
43.95
10 %
Tablets: Acetylcysteinum 600 mg
Zambon Svizzera SA
B / SL
FB
G
IP
CI
Redoxon orange 1g
30 Tablet(s)
PR
PR
k.A.
Effervescent tablets: Acidum Ascorbicum 1 g
Bayer (Schweiz) AG
D
FB
G
IP
CI
Metoject 7.5 mg
PR
PR
k.A.
Injection solution: Methotrexatum 7.5mg / 0.15ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 10 mg
PR
PR
k.A.
Injection solution: Methotrexatum 10mg / 0.2ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 15 mg
PR
PR
k.A.
Injection solution: Methotrexatum 15mg / 0.3ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 20 mg
PR
PR
k.A.
Injection solution: Methotrexatum 20mg / 0.4ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 25 mg
PR
PR
k.A.
Injection solution: Methotrexatum 25mg / 0.5ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 30 mg
PR
PR
k.A.
Injection solution: Methotrexatum 30mg / 0.6ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 12.5 mg
PR
PR
k.A.
Injection solution: Methotrexatum 12.5mg / 0.25ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 17.5 mg
PR
PR
k.A.
Injection solution: Methotrexatum 17.5mg / 0.35ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 22.5 mg
PR
PR
k.A.
Injection solution: Methotrexatum 22.5mg / 0.45ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 27.5 mg
syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 27.5mg / 0.55ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 27.5 mg
PR
PR
k.A.
Injection solution: Methotrexatum 27.5mg / 0.55ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 7.5 mg
4 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 7.5mg / 0.15ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 10 mg
4 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 10mg / 0.2ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 15 mg
4 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 15mg / 0.3ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 20 mg
4 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 20mg / 0.4ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 25 mg
4 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 25mg / 0.5ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 30 mg
4 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 30mg / 0.6ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 12.5 mg
4 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 12.5mg / 0.25ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 17.5 mg
4 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 17.5mg / 0.35ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 22.5 mg
4 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 22.5mg / 0.45ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 27.5 mg
4 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 27.5mg / 0.55ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 7.5 mg
6 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 7.5mg / 0.15ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 10 mg
6 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 10mg / 0.2ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 15 mg
6 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 15mg / 0.3ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 20 mg
6 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 20mg / 0.4ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 25 mg
6 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 25mg / 0.5ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 30 mg
6 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 30mg / 0.6ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 12.5 mg
6 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 12.5mg / 0.25ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 17.5 mg
6 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 17.5mg / 0.35ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 22.5 mg
6 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 22.5mg / 0.45ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 27.5 mg
6 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 27.5mg / 0.55ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 7.5 mg
12 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 7.5mg / 0.15ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 10 mg
12 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 10mg / 0.2ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 15 mg
12 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 15mg / 0.3ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 20 mg
12 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 20mg / 0.4ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 25 mg
12 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 25mg / 0.5ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 30 mg
12 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 30mg / 0.6ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 12.5 mg
12 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 12.5mg / 0.25ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 17.5 mg
12 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 17.5mg / 0.35ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 22.5 mg
12 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 22.5mg / 0.45ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 27.5 mg
12 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 27.5mg / 0.55ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 7.5 mg
24 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 7.5mg / 0.15ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 10 mg
24 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 10mg / 0.2ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 15 mg
24 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 15mg / 0.3ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 20 mg
24 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 20mg / 0.4ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 25 mg
24 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 25mg / 0.5ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 30 mg
24 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 30mg / 0.6ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 12.5 mg
24 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 12.5mg / 0.25ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 17.5 mg
24 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 17.5mg / 0.35ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 22.5 mg
24 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 22.5mg / 0.45ml
Gebro Pharma AG
A
FB
G
IP
CI
Metoject 27.5 mg
24 syringe(s)
PR
PR
k.A.
Injection solution: Methotrexatum 27.5mg / 0.55ml
Gebro Pharma AG
A
FB
G
IP
CI
Lamisil Pedisan Once
4 g
PR
PR
k.A.
Filmogenic solution: Terbinafinum 10 mg/g
Medius AG
D
FB
G
IP
CI
CM
Glimepiride Zentiva 2 mg
30 Tablet(s)
2.81
12.30
k.A.
Tablets: Glimepiridum 2 mg
Helvepharm AG
B
FB
G
IP
CI
CM
Glimepiride Zentiva 2 mg
120 Tablet(s)
9.16
26.40
k.A.
Tablets: Glimepiridum 2 mg
Helvepharm AG
B
FB
G
IP
CI
CM
Glimepiride Zentiva 3 mg
30 Tablet(s)
3.90
13.50
k.A.
Tablets: Glimepiridum 3 mg
Helvepharm AG
B
FB
G
IP
CI
CM
Glimepiride Zentiva 3 mg
120 Tablet(s)
13.39
31.00
k.A.
Tablets: Glimepiridum 3 mg
Helvepharm AG
B
FB
G
IP
CI
CM
Glimepiride Zentiva 4 mg
30 Tablet(s)
4.79
14.45
k.A.
Tablets: Glimepiridum 4 mg
Helvepharm AG
B
FB
G
IP
CI
CM
Glimepiride Zentiva 4 mg
120 Tablet(s)
16.14
33.95
k.A.
Tablets: Glimepiridum 4 mg
Helvepharm AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home